Entries by visicort_admin

Message from Coordinator Prof Matt Griffin

Thank you for your interest in our research project and the VISICORT results. Our international consortium is fully aware that the current situation regarding the Coronavirus disease (COVID-19) is having a significant impact on the research and innovation community. We anticipate that the precise nature of these impacts may evolve over the coming weeks and months. […]

Three new papers attributed to VISICORT!

VISICORT Coordinator Prof Matthew Griffin of the National University of Ireland Galway has recently published three papers acknowledging VISICORT work and funding: Fazekas B and Griffin MD. “Mesenchymal stromal cell-based therapies for acute kidney injury: Progress in the last decade”, Kidney International, In Press, 2020 (Review). 28 January 2020. DOI: https://doi.org/10.1016/j.kint.2019.12.019 Pre-proof available here.  Swaminathan […]

NUI Galway team publishes VISICORT-acknowledged study

The team of Tomás Patrick Griffin, Md Nahidul Islam, Deirdre Wall, John Ferguson, Damian Gerard Griffin, Matthew Dallas Griffin and Paula M. O’Shea from NUI Galway recently published “Plasma dephosphorylated uncarboxylated Matrix Gla-Protein (dp-ucMGP): reference intervals in Caucasian adults and diabetic kidney disease biomarker potential” in the December 2019 edition of the open-access journal Scientific […]

VISICORT consortium meets in Amsterdam

On December 5, 2019, the VISICORT consortium under the leadership of Prof Matthew Griffin at the National University of Ireland Galway met for its final plenary meeting. In Amsterdam for convenience, the partners assembled to share research updates and the progress of the cell manufacturing and clinical trial and to federate its Memorandum of Understanding […]

Prof Dr Uwe Pleyer, Charité presents VISICORT at IOIS 2019 meeting in Taiwan

Prof Dr Uwe Pleyer of Charité Universitätsmedizin Berlin  moderated two sessions at the International Ocular Inflammation Society (IOIS) meeting 2019 in Kaohsiung, Taiwan: “Immunology of Cornea/Sclera– update in diagnosis and therapy” and the “Minimum Clinical Datasets in Uveitis – What is this and do we need it?” The meeting took place on November 13- 16, […]

New VISICORT-acknowledged publication from NUI Galway

“Human mesenchymal stromal cells broadly modulate high glucose-induced inflammatory responses of renal proximal tubular cell monolayers” authored by Md Nahidul Islam, Tomás P. Griffin, Elizabeth Sander, Stephanie Rocks, Junaid Qazi, Joana Cabral, Jasmin McCaul, Tara McMorrow and VISICORT Coordinator Prof Matthew D. Griffin at NUI Galway was published today, the 19th of November 2019. The open-access […]

VISICORT coordinator Prof. Matt Griffin visits leading US medical centre Mayo Clinic to discuss EU-funded mesenchymal stromal cell projects

Prof. Matt Griffin of the National University of Ireland Galway visited the Division of Nephrology and Hypertension and the William J von Liebig Transplant Center at Mayo Clinic, Rochester, Minnesota between September 27th and October 2nd 2019. While there, he engaged with clinical investigators involved in a range of Mayo Clinic research initiatives in regenerative medicine and transplantation. He gave […]

VISICORT PIs chair sessions at EVER 2019 in Nice

The European Association for Vision and Eye Research (EVER) 2019 meeting was held in Nice, France on October 17th- 19th. VISICORT PIs Prof Uwe Pleyer of Charité and Prof Jesper Hjortdal of Aarhus University Hospital were in attendance and very active. VISICORT was represented and acknowledged in several sessions. On Saturday, October 19th Prof Pleyer […]

VISICORT meeting with Epimune Diagnostics

Epimune (www.epimune-dx.com) and the VISICORT Consortium are interested in entering into a collaboration in the field of diagnosis and monitoring of corneal transplant recipients using epigenetic immune cell quantification. The goal of the collaboration is the exploration of epigenetic immune cell quantification to monitor patients after corneal transplantation and to detect (and potentially predict) adverse […]